“Woongjin Thinkbig” Becomes the First Educational Company to Win the CES Innovation Award
SEOUL, South Korea, Dec. 31, 2021 /PRNewswire/ — Woongjin Thinkbig (CEO Lee Jae-jin) will introduce…
SEOUL, South Korea, Dec. 31, 2021 /PRNewswire/ — Woongjin Thinkbig (CEO Lee Jae-jin) will introduce…
Toronto, Ontario–(Newsfile Corp. – December 31, 2021) – Autonomy, security, and stability within the world…
Internet City, Dubai–(Newsfile Corp. – December 31, 2021) – LBank Exchange, a global digital asset…
Internet City, Dubai–(Newsfile Corp. – December 31, 2021) – LBank Exchange, a global digital asset…
A Fund Focused on Beneficiaries of Automation GREENWICH, Conn.–(BUSINESS WIRE)–GAMCO Investors, Inc. (“GAMCO”) (NYSE: GBL)…
LAS VEGAS–(BUSINESS WIRE)–$AGH #AmosKohn—BitNile Holdings, Inc. (NYSE American: NILE), a diversified holding company (“BitNile” or…
LAS VEGAS–(BUSINESS WIRE)–$AGH #AmosKohn—BitNile Holdings, Inc. (NYSE American: NILE), a diversified holding company (“BitNile” or…
HALIFAX, NS / ACCESSWIRE / December 31, 2021 / Silver Tiger Metals Inc. (TSXV:SLVR)(OTCQX:SLVTF) (“Silver…
The Clinic is Accepting New Patients as of Today and Doors Will Be Open January…
GOTHENBURG, SE / ACCESSWIRE / December 31, 2021 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) IRLAB (Nasdaq…
HALIFAX, Nova Scotia, Dec. 30, 2021 (GLOBE NEWSWIRE) — MedMira Inc. (MedMira) (TSXV: MIR), reported…
Key Points: Meeting held with the US Food and Drug Administration’s (FDA) Office of Tissues…
THE WOODLANDS, Texas, Dec. 30, 2021 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today…
NEW YORK and LONDON, Dec. 30, 2021 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX)…
Company announcement – No. 78 / 2021 Total number of shares and voting rights in…
COVAXIN™ whole virus inactivated vaccine generated broad antibody response comparable to those seen in a large…
WOBURN, Mass., Dec. 30, 2021 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company…
Company now expects to release topline 52-week results from MAESTRO-NAFLD-1 in January 2022 CONSHOHOCKEN, Pa.,…
– Positive Phase 3 data in 2nd/3rd line NSCLC (Dublin-3): Superior efficacy benefit in plinabulin…
VANCOUVER, British Columbia, Dec. 30, 2021 (GLOBE NEWSWIRE) — Lotus Ventures Inc. (CSE: J) (OTC:…